Post-marketing surveillance of pirfenidone for idiopathic pulmonary fibrosis in Japan: Interim analysis of 973 patients

被引：0
|
作者：
Ito, Maki [1 ]
Niimi, Yuka [1 ]
Nakamura, Akihiro [1 ]
Kakutani, Shinichi [2 ]
Yoshida, Yuki [2 ]
Yoshikawa, Takayoshi [1 ]
机构：
[1] Shionogi & Co Ltd, Drug Safety Management Dept, Osaka, Japan
[2] Shionogi & Co Ltd, Biostat Dept, Osaka, Japan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Idiopathic pulmonary fibrosis; Interstitial lung disease;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2087
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance
    Murai, Hiroyuki
    Suzuki, Shigeaki
    Hasebe, Miki
    Fukamizu, Yuji
    Rodrigues, Ema
    Utsugisawa, Kimiaki
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [42] EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Inagaki, Ai
    Tsutsumi, Takeo
    Kuriyama, Sachiko
    Nagaoka, Tetsutaro
    Sekiya, Mitsuaki
    Morio, Yoshiteru
    Takahashi, Kazuhisa
    RESPIROLOGY, 2013, 18 : 135 - 135
  • [43] SAFETY AND TOLERABILITY OF NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): ONE-YEAR DATA FROM POST-MARKETING SURVEILLANCE IN THE UNITED STATES
    Maher, T.
    Noth, I.
    Allinger, A.
    Kaul, M.
    Conoscenti, C. S.
    Oelberg, D.
    THORAX, 2016, 71 : A175 - A175
  • [44] Real-world safety of nusinersen in Japan: results from an interim analysis of a post-marketing surveillance and safety database
    Wataya, Takafumi
    Takasaki, Sakura
    Hoshino, Misuzu
    Makioka, Haruki
    Nakamura, Genshu
    Matsuda, Naoto
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (08) : 851 - 863
  • [45] Safety And Tolerability Of Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): One-Year Data From Post-Marketing Surveillance In The United States
    Noth, I.
    Allinger, A.
    Kaul, M.
    Conoscenti, C. S.
    Oelberg, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [46] Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan
    Hayashi, Nobukazu
    Hayama, Koremasa
    Takahashi, Kenzo
    Kurokawa, Ichiro
    Okazaki, Masateru
    Kashiwagi, Tomoko
    Iwashita, Eri
    Terui, Tadashi
    JOURNAL OF DERMATOLOGY, 2022, 49 (04): : 411 - 421
  • [47] Safety analysis of Epzicom ® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan
    Kurita, Tomoko
    Kitaichi, Tomomi
    Nagao, Takako
    Miura, Toshiyuki
    Kitazono, Yoshifumi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (04) : 372 - 381
  • [48] Comment on: CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis
    Rea, Gaetano
    Bocchino, Marialuisa
    EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (10) : 1988 - 1989
  • [49] Long-term safety and effectiveness of stiripentol in patients with Dravet syndrome: Interim report of a post-marketing surveillance study in Japan
    Yamada, Miyuki
    Suzuki, Katsuyoshi
    Matsui, Daisuke
    Inoue, Yushi
    Ohtsuka, Yoko
    EPILEPSY RESEARCH, 2021, 170
  • [50] Safety and Efficacy of Fingolimod in Japanese Patients with Multiple Sclerosis: Interim Analysis Results from Post-marketing Surveillance
    Kira, J.
    Fujihara, K.
    Ueda, K.
    Tajima, T.
    Ueno, M.
    Saida, T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 928 - 928
12345